Universitätsklinikum Köln

Hospital


Location: Köln (Cologne), Germany (DE) DE

ISNI: 000000008852305X

ROR: https://ror.org/05mxhda18

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Hematological immune related adverse events after treatment with immune checkpoint inhibitors (2021) Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, et al. Journal article Role and benefits of infectious diseases (ID) specialists in the COVID-19 pandemics (2021) Tscharntke L, Jung N, Rieg S, Spinner C, Hanses F, Borgmann S, Wille K, et al. Conference contribution Der immunsupprimierte Patient auf der Intensivstation (2021) John S, Kochanek M Journal article Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy (2021) Furlanetto J, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer JU, Lübbe K, et al. Journal article Appendicitis during the COVID-19 lockdown: results of a multicenter analysis in Germany. (2021) Willms AG, Oldhafer KJ, Conze S, Thasler WE, Von Schassen C, Hauer T, Huber T, et al. Journal article Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis. (2021) Tietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, et al. Journal article Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study. (2021) Nickenig G, Friedrichs KP, Baldus S, Arnold M, Seidler T, Hakmi S, Linke A, et al. Journal article Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy (2021) Haas M, Mirocha J, Amann KU, Bajema IM, Barisoni L, Becker JU, Jennette JC, et al. Journal article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article Erratum: AGO Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update (Geburtshilfe Frauenheilkd (2021) 81:10 (1112-1120) DOI: 10.1055/a-1499-8431) (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Paluchowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Erratum